NEW YORK, August 1 – The bioinformatics company MolecularWare has received $2.5 million in first-round funding, the company announced Wednesday.
The Cambridge, Mass.-based company said it would use the money to continue to commercialize its DigitalGenome suite of high throughput analysis software.
The “Series A” funding came from several sources including lead investors Aspen Investment Group and KnowledgeCube Group.
“This capital enables the acceleration of product enhancement and development, along with the acquisition of additional customers and key personnel,” Richard Kivel, CEO of MolecularWare, said in a statement.
MolecularWare customers include the Whitehead Institute, Riken University for Genome Research in Japan, and the University of Tskuba in Japan. MolecularWare was founded in 1999.